CVE-2024-11997
Published: 30 November 2024
Summary
CVE-2024-11997 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Anisha Farmacia. Its CVSS base score is 5.3 (Medium).
Operationally, ranked at the 34.3th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2024-34245
Vulnerability details
A vulnerability was found in code-projects Farmacia 1.0. It has been classified as problematic. This affects an unknown part of the file /vendas.php. The manipulation of the argument notaFiscal leads to cross site scripting. It is possible to initiate the…
more
attack remotely. The exploit has been disclosed to the public and may be used.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Validates web inputs to reject script-related content that could produce XSS.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Makes persistent code injection into loaded programs impossible when the executable image itself resides on hardware-protected read-only media.
Dynamically generated code can be produced and executed inside the isolated chamber, preventing host compromise from code-injection payloads.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.
Directly prevents execution of attacker-supplied code written into data memory regions.